GÖTEBORG, Sweden & COLUMBUS, Ohio--(BUSINESS WIRE)--A study published in the Journal of Oncology Pharmacy Practice shows the use of the PhaSeal System, a closed-system drug transfer device for the ...

Baxa Corporation offers the PhaSeal System Connector which attaches a PhaSeal Injector to an IV line for safe administration of hazardous drugs. The new Luer Lock Connector was redesigned in response ...

GÖTEBORG, Sweden & COLUMBUS, Ohio--(BUSINESS WIRE)--A recent study published in The American Journal of Pharmacy Benefits determined that PhaSeal works to provide a mechanical barrier to the entry of ...

ORLANDO, Fla., Dec. 12, 2013 /PRNewswire/ --ICU Medical, Inc. (NASDAQ: ICUI) today announced that two new studies presented yesterday at the American Society of Health-System Pharmacists (ASHP) ...

Baxa Corporation offers the PhaSeal System Connector which attaches a PhaSeal Injector to an IV line for safe administration of hazardous drugs. The new Luer Lock ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it signed a definitive agreement to acquire Carmel Pharma, Inc., a Swedish company ...

FRANKLIN LAKES, N.J. — Becton, Dickinson and Co. now owns the manufacturer of the PhaSeal system. BD said it has completed its acquisition of Sweden-based Carmel Pharma. Through the deal, BD now owns ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of its acquisition of Carmel Pharma, AB, a Swedish company that manufactures ...

Leading medical technology firm Becton, Dickinson and Company ( BDX) recently revealed that its segment BD Medical received FDA clearance for its BD PhaSeal Closed System Transfer Device as per the ...

> Becton, Dickinson has completed its acquisition of Carmel Pharma, a Swedish company that manufactures the PhaSeal system, a closed-system drug transfer device for the safe handling of hazardous ...

) announced today that it signed a definitive agreement to acquire Carmel Pharma, Inc., a Swedish company that manufactures the PhaSeal® System, the leading closed-system drug transfer device for the ...

BD has a broad product portfolio, including hazardous drug-safe devices such as the PhaSeal and Texium system. It has a global presence spanning more than 50 countries. The BD PhaSeal system works ...